Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03172273
Other study ID # RA-TIPS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 29, 2017
Est. completion date December 31, 2024

Study information

Verified date October 2022
Source Air Force Military Medical University, China
Contact Guohong Han, MD&PhD
Phone 86-13991969930
Email 13991969930@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This multicenter RCT is designed to investigate if TIPS with covered stents improves transplant-free survival for cirrhotic patients with early stage of refractory ascites compared to LVP+albumin during 1 year follow-up period.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Confirmed diagnosis of liver cirrhosis - Recurrent and refractory ascites - Patients with an age between 18 and 65 years old - Child-Pugh =12 - Absence of hepatic encephalopathy - Patient is willing and able to comply with all study protocol requirements, including specified follow-up and testing. - Patient, or legal authorized representative, is willing to provide written informed consent prior to enrollment in the study Exclusion Criteria: - With more than 6 paracenteses within the last 3 months - patients expected to receive transplants within the next 6 months or on waiting list - Usual contra-indication for TIPS: congestive heart failure NYHA>III or medical history of pulmonary hypertension, portal vein thrombosis(>50%), hepatic polycystosis, intra-hepatic bile ducts dilatation - Patient has had previous TIPS placement - Severe liver dysfunction by: Prothrombin index < 40% or total bilirubin > 50µmol/l - Serum creatinine >133µmol/l - Severe hyponatremia <125mmol / L - Uncontrolled sepsis - Gastrointestinal hemorrhage within 6 weeks of randomization - Known allergy to albumin - Pregnant or breast feeding women - Refusal to participate or patient unable to receive informations or to sign written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
TIPS
Transjugular intrahepatic portosystemic shunt with covered PTFE
paracentesis
paracentasis plus albumine invision

Locations

Country Name City State
China the First Affiliated Hospital, Air Force Medical University Xi'an Shaanxi
China Xi'an International Medical Center Hospital Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Air Force Military Medical University, China

Country where clinical trial is conducted

China, 

References & Publications (2)

Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014 Mar 14;20(10):2704-14. doi: 10.3748/wjg.v20.i10.2704. Review. — View Citation

Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, Péron JM, Vinel JP. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology. 2017 Jan;152(1):157-163. doi: 10.1053/j.gastro.2016.09.016. Epub 2016 Sep 20. Erratum in: Gastroenterology. 2017 Sep;153(3):870. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Transplant-free survival 12 months
Secondary Frequency of paracentesis 12 months
Secondary Frequency of overt Hepatic Encephalopathy Number of episodes of West Haven grade 2 or greater without precipitating factor 12 months
Secondary Nutritional status 12 months
Secondary Quality of life 12 months
Secondary Other Liver Disease Complications (Adverse Events) 12 months
See also
  Status Clinical Trial Phase
Terminated NCT03219372 - Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence Phase 2
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Recruiting NCT04057287 - Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)
Recruiting NCT04089878 - "To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt N/A
Completed NCT04212286 - Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC N/A
Completed NCT04474743 - Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study
Recruiting NCT03694691 - Developing Viability Index for Machine Perfused Livers N/A
Terminated NCT04072601 - Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis Phase 4
Terminated NCT03878563 - Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)
Terminated NCT04160039 - Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit N/A
Recruiting NCT04191369 - EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients. N/A
Completed NCT03083925 - Viatorr CX Case-control Study for Complications of Portal Hypertension
Not yet recruiting NCT03855709 - Antibiotic-resistant Bacterial Infection of Hepatic Patients
Recruiting NCT02484573 - Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol) N/A
Recruiting NCT04357600 - Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B Phase 1/Phase 2
Completed NCT03156426 - Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis
Active, not recruiting NCT03868397 - Preoperative Portal and Splanchnic Flow Measurement Using MRI N/A
Terminated NCT03650660 - Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
Completed NCT03871894 - Indirect Calorimeter Based Study in Patients With Liver Cirrhosis N/A
Completed NCT03283176 - Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin